Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
AIDS and Behavior
Erschienen in: AIDS and Behavior 3/2018

06.03.2017

The Role of Emotional Avoidance, the Patient–Provider Relationship, and Other Social Support in ART Adherence for HIV+ Individuals

verfasst von: Christopher R. Berghoff, Kim L. Gratz, Kaitlin J. Portz, Megan Pinkston, James A. Naifeh, Shenell D. Evans, Deborah J. Konkle-Parker, Matthew T. Tull

Erschienen in: AIDS and Behavior | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Adherence to antiretroviral therapy (ART) is associated with positive health outcomes among HIV+ patients. However, non-adherence remains high. Though factors that account for non-adherence remain unclear, social support has been consistently associated with ART adherence. As such, identifying malleable factors that hinder patients’ ability to form supportive relationships may have consequence for improving ART adherence. Emotional avoidance (EA) may be one such factor given that it has been linked to difficulties in social situations. The present study examined relations among EA, the patient–provider relationship, other sources of social support, and ART adherence within a sample of HIV+ ART-prescribed patients. High EA was related to poor adherence and patient–provider relationships. EA was indirectly related to poor adherence through poorer patient–provider interactions. The indirect relation of EA to ART adherence through other sources of social support was not significant. Implications for developing targeted behavioral interventions focused on improving ART adherence are discussed.
Literatur
1.
Carballo E, Cadarso-Suarez C, Carrera I, et al. Assessing relationships between health-related quality of life and adherence to antiretroviral therapy. Qual Life Res. 2004;13(3):587–99.PubMedCrossRef
2.
Catz SL, Kelly JA, Bogart LM, Benotsch EB, McAuliffe TL. Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychol. 2000;19(2):124–33.PubMedCrossRef
3.
Colbert AM, Sereika SM, Erlen JA. Functional health literacy, medication-taking self-efficacy and adherence to antiretroviral therapy. J Adv Nurs. 2013;69(2):295–304.PubMedCrossRef
4.
Gifford AL, Bormann JE, Shively MJ, Wright BC, Richman DD, Bozzette SA. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. J Acquir Immune Defic Syndr. 2000;23(5):386–95.PubMedCrossRef
5.
Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133(1):21–30.PubMedCrossRef
6.
Mannheimer S, Friedland G, Matts J, Child C, Chesney M. The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials. Clin Infect Dis. 2002;34(8):1115–21.PubMedCrossRef
7.
Singh N, Berman SM, Swindells S, et al. Adherence of human immunodeficiency virus-infected patients to antiretroviral therapy. Clin Infect Dis. 1999;29(4):824–30.PubMedCrossRef
8.
Bangsberg DR, Pery S, Carlebois E, et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001;15(9):1181–3.PubMedCrossRef
9.
Mannheimer SB, Matts J, Telzak E, et al. Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence. AIDS Care. 2005;17(1):10–22.PubMedCrossRef
10.
Eldred LJ, Wu AW, Chaisson RE, Moore RD. Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18(2):117–25.PubMedCrossRef
11.
Safren SA, Biello KB, Smeaton L, et al. Psychosocial predictors of non-adherence and treatment failure in a large scale multi-national trial of antiretroviral therapy for HIV: data from the ACTG A5175/PEARLS trial. PLoS ONE. 2014;9(8):e104178.PubMedPubMedCentralCrossRef
12.
Ortego C, Huedo-Medina TB, Llorca J, et al. Adherence to highly active antiretroviral therapy (HAART): a meta-analysis. AIDS Behav. 2011;15(7):1381–96.PubMedCrossRef
13.
Azar P, Wood E, Nguyen P, et al. Drug use patterns associated with risk of non-adherence to antiretroviral therapy among HIV-positive illicit drug users in a Canadian setting: a longitudinal analysis. BCM Infect Dis. 2015;15(193):1–6.
14.
Uthman OA, Magidson JF, Safren SA, Nachega JB. Depression and adherence to antiretroviral therapy in low-, middle- and high-income countries: a systematic review and meta-analysis. Curr HIV/AIDS Rep. 2014;11(3):291–307.PubMedPubMedCentralCrossRef
15.
Mohammadpour A, Yekta ZP, Nikbakht Nasrabadi AR. HIV-infected patients’ adherence to highly active antiretroviral therapy: a phenomenological study. Nurs Health Sci. 2010;12(4):464–9.PubMedCrossRef
16.
Roberts KJ, Mann T. Barriers to antiretroviral medication adherence in HIV-infected women. AIDS Care. 2000;12(4):377–86.PubMedCrossRef
17.
Altice FL, Mostashari F, Friedland GH. Trust and the acceptance of and adherence to antiretroviral therapy. J Acquir Immune Defic Syndr. 2001;28(1):47–58.PubMedCrossRef
18.
Cox LE. Social support, medication compliance and HIV/AIDS. Soc Work Health Care. 2002;35(1–2):425–60.PubMedCrossRef
19.
Vyavaharkar M, Moneyham L, Tavakoli A, et al. Social support, coping, and medication adherence among HIV-positive women with depression living in rural areas of the southeastern United States. AIDS Patient Care STDs. 2007;21(9):667–80.PubMedCrossRef
20.
Corless IB, Guarino AJ, Nicholas PK, et al. Mediators of antiretroviral adherence: a multisite international study. AIDS Care. 2013;25(3):364–77.PubMed
21.
Ingersoll KS, Heckman CJ. Patient–clinician relationships and treatment system effects on HIV medication adherence. AIDS Behav. 2005;9(1):89–101.PubMedPubMedCentralCrossRef
22.
Lewis MP, Colbert A, Erlen J, Meyers M. A qualitative study of persons who are 100% adherent to antiretroviral therapy. AIDS Care. 2006;18(2):140–8.PubMedCrossRef
23.
Mills EJ, Nachega JB, Bangsberg DR, et al. Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med. 2006;3(11):e438.PubMedPubMedCentralCrossRef
24.
Roberts KJ. Physician-patient relationships, patient satisfaction, and antiretroviral medication adherence among HIV-infected adults attending a public health clinic. AIDS Patient Care STDs. 2002;16(1):43–50.PubMedCrossRef
25.
Russell J, Krantz S, Neville S. The patient–provider relationship and adherence to highly active antiretroviral therapy. J Assoc Nurses AIDS Care. 2005;15(5):40–7.CrossRef
26.
27.
Arbuthnott A, Sharpe D. The effect of physician-patient collaboration on patient adherence in non-psychiatric medicine. Patient Educ Couns. 2009;77(1):60–7.PubMedCrossRef
28.
Langebeek N, Gisolf EH, Reiss P, et al. Predictors and correlates of adherence to combination antiretroviral therapy (ART) for chronic HIV infection: a meta-analysis. BCM Med. 2014;12(142):1–14.
29.
Gonzalez JS, Penedo FJ, Antoni MH, et al. Social support, positive states of mind, and HIV treatment adherence in men and women living with HIV/AIDS. Health Psychol. 2004;23(4):413–8.PubMedCrossRef
30.
Taylor CT, Laposa JM, Alden LE. Is avoidant personality disorder more than just social avoidance? J Pers Disord. 2004;18(6):571–94.PubMedCrossRef
31.
Chapman AL, Rosenthal MZ. Helping clients overcome avoidance. In: Managing therapy-interfering behavior: Strategies from dialectical behavior therapy. Washington, DC: American Psychological Association; 2016:167–94.
32.
Campbell-Sills L, Barlow DH, Brown TA, Hofman SG. Effects of suppression and acceptance on emotional responses of individuals with anxiety and mood disorders. Behav Res Ther. 2006;44(9):1251–63.PubMedCrossRef
33.
Levitt JT, Brown TA, Orsillo SM, Barlow DH. The effects of acceptance versus suppression of emotion on subjective and psychophysiological response to carbon dioxide challenge in patients with panic disorder. Behav Ther. 2004;35(4):747–66.CrossRef
34.
Gross JJ, John OP. Individual differences in two emotion regulation processes: implications for affect, relationships, and well-being. J Pers Soc Psychol. 2003;85(2):348–62.PubMedCrossRef
35.
Kahn JH, Garrison AM. Emotional self-disclosure and emotional avoidance: relations with symptoms of depression and anxiety. J Couns Psychol. 2009;56(4):573–84.CrossRef
36.
Hayes SC, Strosahl KD, Wilson KG, et al. Measuring experiential avoidance: a preliminary test of a working model. Psychol Rec. 2004;54:553–78.CrossRef
37.
Gerhart JI, Baker CN, Hoerger M, Ronan GF. Experiential avoidance and interpersonal problems: a moderated mediation model. J Context Behav Sci. 2014;3(4):291–8.CrossRef
38.
Reddy MK, Meis LA, Erbes CR, Polusny MA, Compton JS. Associations among experiential avoidance, couple adjustment, and interpersonal aggression in returning Iraqi war veterans and their partners. J Consult Clin Psychol. 2011;79(4):515–20.PubMedCrossRef
39.
Tull MT, Jakupcak M, Paulson A, Gratz KL. The role of emotional inexpressivity and experiential avoidance in the relationship between posttraumatic stress disorder symptom severity and aggressive behavior among men exposed to interpersonal violence. Anxiety Stress Coping. 2007;20(4):337–51.PubMedCrossRef
40.
Stanton AL, Danoff-Burg S, Cameron CL, et al. Emotionally expressive coping predicts psychological and physical adjustment to breast cancer. J Consult Clin Psychol. 2000;68(5):875–82.PubMedCrossRef
41.
Stanton AL, Kirk SB, Cameron CL, Danoff-Burg S. Coping through emotional approach: scale construction and validation. J Pers Soc Psychol. 2000;78(6):1150–69.PubMedCrossRef
42.
Graham SM, Huang JY, Clark MS, Helgeson VS. The positives of negative emotions: willingness to express negative emotions promotes relationships. Pers Soc Psychol Bull. 2008;34(3):394–406.PubMedCrossRef
43.
Naifeh JA, Tull MT, Gratz KL. Anxiety sensitivity, emotional avoidance, and PTSD symptom severity among crack/cocaine dependent patients in residential treatment. Cognit Ther Res. 2012;36(3):247–57.PubMedCrossRef
44.
Tull MT, Hahn KS, Evans SD, Salters-Pedneault K, Gratz KL. Examining the role of emotional avoidance in the relationship between posttraumatic stress disorder symptom severity and worry. Cogn Behav Ther. 2011;40(1):5–14.PubMedCrossRef
45.
Bakken S, Holzemer WL, Brown M, et al. Relationships between perception of engagement with health care provider and demographic characteristics, health status, and adherence to therapeutic regimen in persons with HIV/AIDS. AIDS Patient Care STDs. 2000;14(4):189–97.PubMedCrossRef
46.
Metsch LR, Pereyra M, Colfax G, et al. HIV-positive patients’ discussion of alcohol use with their HIV primary care providers. Drug Alcohol Depend. 2008;95(1–2):37–44.PubMedCrossRef
47.
Zimet GD, Dahlem NW, Zimet SG, Farley GK. The multidimensional scale of perceived social support. J Pers Assess. 1988;52(1):30–41.CrossRef
48.
Zimet GD, Powell SS, Farley GK, Werkman S, Berkoff KA. Psychometric characteristics of the multidimensional scale of perceived social support. J Pers Assess. 1990;55(3–4):610–7.PubMedCrossRef
49.
Nelson A, Gupta S, Trautner BW, et al. Intention to adhere to HIV treatment: a patient-centered predictor of antiretroviral adherence. HIV Med. 2013;14(8):472–80.CrossRef
50.
Kalichman SC, Amaral CM, Swetzes C, et al. A simple single-item rating scale to measure medication adherence: further evidence for convergent validity. J Int Assoc Physicians AIDS Care. 2009;8(6):367–74.CrossRef
51.
Lu M, Safren SA, Skolnik PR, et al. Optimal recall period and response task for self-reported HIV medication adherence. AIDS Behav. 2008;12(1):86–94.PubMedCrossRef
52.
Feldman BJ, Fredericksen RJ, Crane PK, et al. Evaluation of the single-item self-rating adherence scale for use in routine clinical care of people living with HIV. AIDS Behav. 2013;17(1):307–18.PubMedPubMedCentralCrossRef
53.
Buscher A, Hartman C, Kallen MA, Giordano TP. Validity of self-report measures in assessing antiretroviral adherence of newly diagnosed, HAART-naïve, HIV patients. HIV Clin Trials. 2011;12(5):244–54.PubMedPubMedCentralCrossRef
54.
Wilson IB, Carter AE, Berg KM. Improving the self-report of HIV antiretroviral medication adherence: is the glass half full or half empty? Curr HIV/AIDS Rep. 2009;6(4):177–86.PubMedPubMedCentralCrossRef
55.
Gribble JN, Miller HG, Rogers SM, Turner CF. Interview mode and measurement of sexual behaviors: methodological issues. J Sex Res. 1999;36(1):16–24.PubMedPubMedCentralCrossRef
56.
Turner CF, Ku L, Rogers SM, Lindberg LD, Pleck JH, Sonenstein FL. Adolescent sexual behavior, drug use, and violence: increased reporting with computer survey technology. Science. 1998;280(5365):867–973.PubMedCrossRef
57.
Wildes JE, Ringham RM, Marcus MD. Emotion avoidance in patients with anorexia nervosa: initial test of a functional model. Int J Eat Disord. 2010;43(5):398–404.PubMedPubMedCentral
58.
Hayes A. Introduction to mediation, moderation, and conditional process analysis: A regression-based approach. New York: Guilford Press; 2013.
59.
Lucas GM, Wu AW, Cheever LW. Adherence to antiretroviral therapy: an update of current concepts. Curr HIV/AIDS Rep. 2004;1(4):172–80.PubMedCrossRef
60.
Harrington J, Noble LM, Newman SP. Improving patients’ communication with doctors: a systematic review of intervention studies. Patient Educ Couns. 2004;52(1):7–16.PubMedCrossRef
61.
Sandelowski M, Voils CI, Chang Y, Lee E. A systematic review comparing antiretroviral adherence descriptive and intervention studies. AIDS Care. 2009;21(8):953–66.PubMedPubMedCentralCrossRef
62.
Beach MC, Roter DL, Saha S, et al. Impact of a brief patient and provider intervention to improve the quality of communication about medication adherence among HIV patients. Patient Educ Couns. 2015;98(9):1078–83.PubMedPubMedCentralCrossRef
63.
Amico KR, Harman JJ, Johnson BT. Efficacy of antiretroviral therapy adherence interventions: a research synthesis of trials, 1996–2004. J Acquir Immune Defic Syndr. 2006;41(3):285–97.PubMedCrossRef
64.
Scanlon ML, Vreeman RC. Current strategies for improving access and adherence to antiretroviral therapies in resource-limited settings. HIV/AIDS. 2013;5:1–17.PubMedPubMedCentral
65.
de Bruin M, Viechtbauer W, Schaalma HP, Kok G, Abraham C, Hospers HJ. Standard care impact on effects of highly active antiretroviral therapy adherence interventions: a meta-analysis of randomized controlled trials. Arch Intern Med. 2010;170(3):240–50.PubMedCrossRef
66.
Easthall C, Song F, Bhattacharya D. A meta-analysis of cognitive-based behaviour change techniques as interventions to improve medication adherence. BMJ Open. 2013;3(8):e002749.PubMedPubMedCentralCrossRef
67.
Mannheimer SB, Morse E, Matts JP, et al. Sustained benefit from a long-term antiretroviral adherence intervention. J Acquir Immune Defic Syndr. 2006;43(Suppl 1):S41–7.PubMedCrossRef
68.
Simoni JM, Pearson CR, Pantalone DW, Marks G, Crepaz N. Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load: a meta-analytic review of randomized controlled trials. J Acquir Immune Defic Syndr. 2006;43(Suppl 1):S23–35.PubMedPubMedCentralCrossRef
69.
Zolnierek KBH, DiMatteo MR. Physician communication and patient adherence to treatment: a meta-analysis. Med Care. 2009;47(8):826–34.PubMedCrossRef
70.
Bond FW, Hayes SC, Baer RA, et al. Preliminary psychometric properties of the acceptance and action questionnaire-II: a revised measure of psychological inflexibility and experiential avoidance. Behav Ther. 2011;42(4):676–88.PubMedCrossRef
71.
Hayes SC, Strosahl KD, Wilson KG. Acceptance and commitment therapy, second edition: The process and practice of mindful change. New York: The Guilford Press; 2011.
72.
A-Tjak JGL, Davis ML, Morina N, Powers MB, Smits JAJ, Emmelkamp PMG. A meta analysis of the efficacy of acceptance and commitment therapy for clinically relevant mental and physical health problems. Psychother Psychosom. 2015;84:30–6.PubMedCrossRef
73.
Dindo L. One-day acceptance and commitment training workshops in medical populations. Curr Opin Psychol. 2005;2:38–42.CrossRef
74.
Hann KEJ, McCracken LM. A systematic review of randomized controlled trials of acceptance and commitment therapy for adults with chronic pain: outcome domains, design quality, and efficacy. J Context Behav Sci. 2014;3(4):217–27.CrossRef
75.
Moitra E, Herbert JD, Forman EM. Acceptance-based behavior therapy to promote HIV medication adherence. AIDS Care. 2011;23(12):1660–7.PubMedCrossRef
76.
77.
Li L, Lee S, Thammawijaya P, Jiraphongsa C, Rotheram-Borus MJ. Stigma, social support, and depression among people living with HIV in Thailand. AIDS Care. 2009;21(8):1007–13.PubMedPubMedCentralCrossRef
78.
Brashers DE, Neidig JL, Goldsmith DJ. Social support and the management of uncertainty for people living with HIV or AIDS. Health Commun. 2004;16(3):305–31.PubMedCrossRef
79.
Spring R. Support groups for people living with HIV/AIDS: a review of literature. J Assoc Nurses AIDS Care. 1998;9(4):43–55.CrossRef
80.
McDowell TL, Serovich JM. The effect of perceived and actual social support on the mental health of HIV-positive persons. AIDS Care. 2007;19(10):1223–9.PubMedPubMedCentralCrossRef
81.
Brockmeyer T, Holtforth MG, Pfeiffer N, Backenstrass M, Friederich H, Bents H. Mood regulation expectancies and emotion avoidance in depression vulnerability. Personal Individ Differ. 2012;53:351–4.CrossRef
82.
Kelly MM, Forsyth JP. Associations between emotional avoidance, anxiety sensitivity, and reactions to an observational fear challenge procedure. Behav Res Ther. 2009;47(4):331–8.PubMedCrossRef
83.
Levin ME, Lillis J, Seeley J, Hayes SC, Pistorello J, Biglan A. Exploring the relationship between experiential avoidance, alcohol use disorders and alcohol-related problems among first-year college students. J Am Coll Heath. 2012;60(6):443–8.CrossRef
84.
Stewart SH, Zvolensky MJ, Eifert GH. The relations of anxiety sensitivity, experiential avoidance, and alexithymic coping to young adults’ motivations for drinking. Behav Modif. 2002;26(2):274–96.PubMedCrossRef
85.
Tull MT, Rodman SA, Roemer L. An examination of the fear of bodily sensations and body hypervigilance as predictors of emotion regulation difficulties among individuals with a recent history of uncued panic attacks. J Anxiety Disord. 2008;22(4):750–60.PubMedCrossRef
86.
Arnsten JH, Li X, Minzuno Y, et al. Factors associated with antiretroviral therapy adherence and medication errors among HIV-infected injection drug users. J Acquir Immune Defic Syndr. 2007;46(Suppl 2):S64–71.PubMedCrossRef
87.
Mellins CA, Havens JF, McDonnell C, et al. Adherence to antiretroviral medications and medical care in HIV-infected adults diagnosed with mental and substance abuse disorders. AIDS Care. 2009;21(2):168–77.PubMedPubMedCentralCrossRef
88.
Parsons JT, Kowalczyk W, Botsko M, Tomassilli J, Golub SA. Aggregate versus day level association between methamphetamine use and HIV medication non-adherence among gay and bisexual men. AIDS Behav. 2013;17(4):1478–87.PubMedPubMedCentralCrossRef
89.
Parsons JT, Rosof E, Mustanski B. Patient-related factors predicting HIV medication adherence among men and women with alcohol problems. J Health Psychol. 2007;12(2):357–70.PubMedPubMedCentralCrossRef
90.
Martin LR, Williams SL, Haskard KB, DiMatteo MR. The challenge of patient adherence. Ther Clin Risk Manag. 2005;1(3):189–99.PubMedPubMedCentral
91.
Cheung KW, Mak YW. Association between psychological flexibility and health beliefs in the uptake of influenza vaccination among people with chronic respiratory diseases in Hong Kong. Int J Environ Res Public Health. 2016;13(2):155.PubMedPubMedCentralCrossRef
92.
Berghoff CR, Tull MT, DiLillo D, Messman-Morre T, Gratz KL. The role of experiential avoidance in the relation between anxiety disorder diagnoses and future physical health symptoms in a community sample of young adult women. J Context Behav Sci. 2016. doi:10.​1016/​j.​jcbs.​2016.​11.​002.
93.
Chartier M, Vinatieri T, DeLonga K, McGlynn LM, Gore-Felton C, Koopman C. A pilot study investigagting the effects of trauma, experiential avoidance, and disease management in HIV-positive MSM using methamphetamine. J Int Assoc Physicians AIDS Care. 2010;9(2):78–81.CrossRef
94.
Walker JG, Jackson HJ, Littlejohn GO. Models of adjustment to chronic illness: using the example of rheumatoid arthritis. Clin Psychol Rev. 2004;24(4):461–88.PubMedCrossRef
95.
Baumgartner LM. The incorporation of the HIV/AIDS identity into the self over time. Qual Health Res. 2007;17(7):919–31.PubMedCrossRef
96.
An PG, Rabatin JS, Manwell LB, et al. Burden of difficult encounters in primary care: data from the minimizing error, maximizing outcomes study. Arch Intern Med. 2009;169(4):410–4.PubMedCrossRef
97.
DiMatteo MR, Sherbourne CD, Hays RD, et al. Physicians’ characteristics influence patients’ adherence to medical treatment: results from the Medical Outcomes Study. Health Psychol. 1993;12(2):93–102.PubMedCrossRef
98.
Panagioti M, Panagopoulou E, Bower P, et al. Controlled interventions to reduce burnout in physicians: a systematic review and meta-analysis. JAMA Intern Med. 2017;177(2):195–205.PubMedCrossRef
99.
Stewart CG, White R, Ebert B, Mays I, Nardozzi J, Bockarie H. A preliminary evaluation of Acceptance and Commitment Therapy (ACT) training in Sierra Leone. J Context Behav Sci. 2016;5(4):16–22.CrossRef
100.
Nieuwkerk PT, Oort JF. Self-reported adherence to antiretroviral therapy for HIV-1 infection and virologic treatment response: a meta-analysis. J Acquir Immune Defic Syndr. 2005;38(4):445–8.PubMedCrossRef
101.
Simoni JM, Kurth AE, Pearson CR, Pantalone DW, Merrill JO, Frick PA. Self-report measures of antiretroviral therapy adherence: a review with recommendations for HIV research and clinical management. AIDS Behav. 2006;10(3):227–45.PubMedPubMedCentralCrossRef
102.
Shi L, Liu J, Koleva Y, Fonseca V, Kalsekar A, Pawaskar M. Concordance of adherence measurement using self-reported adherence questionnaires and medication monitoring devices. Pharmacoeconomics. 2010;28(12):1097–107.PubMedCrossRef
103.
Wang H, Zhou J, He G, et al. Consistent ART adherence is associated with improved quality of life, CD4 counts, and reduced hospital costs in central China. AIDS Res and Hum Retrovir. 2009;25(8):757–63.CrossRef
Metadaten
Titel
The Role of Emotional Avoidance, the Patient–Provider Relationship, and Other Social Support in ART Adherence for HIV+ Individuals
verfasst von
Christopher R. Berghoff
Kim L. Gratz
Kaitlin J. Portz
Megan Pinkston
James A. Naifeh
Shenell D. Evans
Deborah J. Konkle-Parker
Matthew T. Tull
Publikationsdatum
06.03.2017
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 3/2018
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-017-1745-2

Weitere Artikel der Ausgabe 3/2018

AIDS and Behavior 3/2018 Zur Ausgabe

Original Paper

The Role of the Primary Romantic Relationship in HIV Care Engagement Outcomes Among Young HIV-Positive Black Men Who Have Sex with Men

Original Paper

HIV Linkage to Care and Retention in Care Rate Among MSM in Guangzhou, China

Original Paper

A Mixed-Methods Exploration of the Needs of People Living with HIV (PLWH) Enrolled in Access to Care, a National HIV Linkage, Retention and Re-Engagement in Medical Care Program

Original Paper

“It’s Never Just About the HIV:” HIV Primary Care Providers’ Perception of Substance Use in the Era of “Universal” Antiretroviral Medication Treatment

Original Paper

Influence of Side Effects on ART Adherence Among PLWH in China: The Moderator Role of ART-Related Knowledge

Original Paper

Improving AIDS Care After Trauma (ImpACT): Pilot Outcomes of a Coping intervention Among HIV-Infected Women with Sexual Trauma in South Africa

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 | Hypertonie | Nachrichten

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 | Nierenkarzinom | Nachrichten

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 | NSCLC | Nachrichten

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC
weitere anzeigen

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise